Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YMAB
2701
DELISTED
Y-mAbs Therapeutics
YMAB
| $956K | ﹤0.01% |
+41,800
| New | +$960K |
|
2702
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
| $955K | ﹤0.01% |
10,718
+6,900
| +181% | +$606K |
|
|
AXU
2703
DELISTED
Alexco Resource Corp
AXU
| $955K | ﹤0.01% |
837,950
+169,400
| +25% | +$177K |
|
|
LBY
2704
DELISTED
Libbey, Inc.
LBY
| $952K | ﹤0.01% |
511,800
+43,800
| +9% | +$101K |
|
|
MYND
2705
Mynd.ai
MYND
$18.9M
| $942K | ﹤0.01% |
14,054
+7,404
| +111% | +$531K |
|
2706
Prologis
PLD
$136B
| $942K | ﹤0.01% |
11,766
-873,841
| -99% | -$66.5M |
|
|
CTHR
2707
DELISTED
Charles & Colvard Ltd
CTHR
| $940K | ﹤0.01% |
59,507
+35,280
| +146% | +$535K |
|
|
NAAS
2708
NaaS Technology Inc
NAAS
$54.7M
| $939K | ﹤0.01% |
12
+6
| +100% | +$464K |
|
2709
Tecnoglass
TGLS
$1.99B
| $929K | ﹤0.01% |
143,121
-30,015
| -17% | -$207K |
|
2710
Prestige Consumer Healthcare
PBH
$2.47B
| $928K | ﹤0.01% |
+29,300
| New | +$871K |
|
2711
Twist Bioscience
TWST
$5.32B
| $928K | ﹤0.01% |
+32,000
| New | +$846K |
|
2712
First Trust Capital Strength ETF
FTCS
$8.05B
| $926K | ﹤0.01% |
16,400
+4,600
| +39% | +$254K |
|
|
HWCC
2713
DELISTED
Houston Wire & Cable Company
HWCC
| $926K | ﹤0.01% |
176,700
+3,700
| +2% | +$21.4K |
|
2714
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.81B
| $920K | ﹤0.01% |
+27,822
| New | +$914K |
|
|
RDGT
2715
Ridgetech Inc
RDGT
$2.79M
| $920K | ﹤0.01% |
23
-1
| -4% | -$51K |
|
|
TAIT
2716
DELISTED
Taitron Components
TAIT
| $918K | ﹤0.01% |
286,996
+136,106
| +90% | +$499K |
|
|
STRR
2717
Star Equity Holdings
STRR
$40.1M
| $917K | ﹤0.01% |
73,619
+2,909
| +4% | +$42.3K |
|
2718
ProShares Ultra QQQ
QLD
$11.7B
| $912K | ﹤0.01% |
76,000
+54,392
| +252% | +$637K |
|
|
SECO
2719
DELISTED
Secoo Holding Limited ADR
SECO
| $911K | ﹤0.01% |
11,990
-7,593
| -39% | -$654K |
|
2720
Emerson Radio
MSN
$7.91M
| $909K | ﹤0.01% |
882,150
+2,700
| +0.3% | +$3.14K |
|
2721
Pluri
PLUR
$17M
| $909K | ﹤0.01% |
18,298
-1,460
| -7% | -$73.1K |
|
2722
Scully Royalty
SRL
$75.4M
| $909K | ﹤0.01% |
68,370
+9,700
| +17% | +$111K |
|
|
AMJ
2723
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $906K | ﹤0.01% |
36,100
+15,300
| +74% | +$385K |
|
|
WLH
2724
DELISTED
WILLIAM LYON HOMES
WLH
| $906K | ﹤0.01% |
49,700
+20,959
| +73% | +$378K |
|
2725
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11B
| $905K | ﹤0.01% |
8,600
-5,200
| -38% | -$543K |
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 495 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.